New Key Statistics Module, Z-Score and F-Score
HKSE:02269 Key Ratios
Market Cap HK$ M | 60,327.68 |
Enterprise Value HK$ M | 51,634.69 |
P/E(ttm) | 17.29 |
PE Ratio without NRI | 12.56 |
Forward PE Ratio | 13.00 |
Price/Book | 1.41 |
Price/Sales | 3.40 |
Price/Free Cash Flow | 132.36 |
Price/Owner Earnings | 428.24 |
Payout Ratio % | -- |
Revenue (TTM) HK$ M | 18,631.00 |
EPS (TTM) HK$ | 0.84 |
Beneish M-Score | -2.48 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | 46.70 |
y-y EBITDA Growth Rate % | -12.80 |
EV-to-EBIT | 10.90 |
EV-to-EBITDA | 10.90 |
PEG | 0.27 |
Shares Outstanding M | 4,162.63 |
Net Margin (%) | 19.96 |
Operating Margin % | 26.13 |
Pre-tax Margin (%) | 24.50 |
Quick Ratio | 2.54 |
Current Ratio | 2.78 |
ROA % (ttm) | 6.40 |
ROE % (ttm) | 8.96 |
ROIC % (ttm) | 9.45 |
Dividend Yield % | -- |
Altman Z-Score | 3.82 |
HKSE:02269 Number of Guru Trades
HKSE:02269 Volume of Guru Trades
Gurus Latest Trades with HKSE:02269
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
HKSE:02269 is held by these investors
Total 1
WuXi Biologics (Cayman) Inc Insider Transactions
No Available Data